ARTELO BIOSCIENCES, INC. Debt Securities, Available-for-sale, Unrealized Gain (Loss)
ARTELO BIOSCIENCES, INC. (ARTL) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of $0 for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2024-08-13
- ARTELO BIOSCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-06-30 was $0.00.
- ARTELO BIOSCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- ARTELO BIOSCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2023-06-30 was -$29.00K.
- ARTELO BIOSCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2023-03-31 was $29.00K.
- ARTELO BIOSCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2023 was $0.00.
- ARTELO BIOSCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2022 was -$24.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month |
|---|---|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 | ||
| 2023-12-31 | $0.00 10-K · filed 2024-03-25 | ||
| 2023-06-30 | -$29.00K 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $29.00K 10-Q · filed 2024-05-13 | ||
| 2022-12-31 | -$24.00K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |